2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl]phenoxy] acetic acid (BMY 42393): 2) oral activity and efficacy in animal models of arterial thrombosis
- 1 April 1994
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 74 (2) , 125-133
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antithrombotic activity of BMY-43351, a new imidazoquinoline with enhanced aqueous solubilityThrombosis Research, 1991
- Primate vascular responses to octimibate, a non‐prostanoid agonist at the prostacyclin receptorBritish Journal of Pharmacology, 1991
- Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2-imidazo[4,5-]quinolin-2-one (BMY-20844)Thrombosis Research, 1989
- [1] Isolation of human platelets from plasma by centrifugation and washing1989
- [4] Isolation of platelets from laboratory animals1989
- Suppression of principal atherosclerotic mechanisms by prostacyclinc and other eicosanoidsProgress in Lipid Research, 1986
- On the identification and biological properties of prostaglandin J2Prostaglandins, Leukotrienes and Medicine, 1984
- Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?Circulation, 1982